NCT00834951已完成2 期
A Prospective Multicenter Phase II Study of MabThera (Rituximab) Plus 2 Weekly CHOP Followed by Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
The purpose of this study is to determine whether the application of low dose total body irradiation following chemo-immuntherapy in elderly patients with aggressive with non-Hodgkin's lymphoma would be safe and potentially benecicial adjuvant therapy
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 60 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •previously untreated, pathology verified aggressive non-Hodgkin lymphoma of the diffuse large B-cell type according to the WHO classification. Age between 60 years and 80 years.Positive for an anti-CD20 antibody. Good performance status and normal initial normal blood count.
排除标准
- •Patients with previous lymphoma associated with immune suppression of any sort. Diagnosis or history of indolent lymphoma or other malignancies. Marked impairment of any vital organ such as the heart, lung, liver or kidneys.
研究者
相似试验
已完成
2 期
Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients With Implant ReconstructionsBreast CancerNCT02086578Memorial Sloan Kettering Cancer Center100
已完成
2 期
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell TransplantationMyelodysplastic SyndromesMyeloproliferative DisorderAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaT-cell LymphomaNon Hodgkin LymphomaB-cell LymphomaHodgkin LymphomaChronic Myelomonocytic LeukemiaNCT03734601Stanford University22
终止
2 期
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHCIntrahepatic CholangiocarcinomaNCT02254681Allina Health System6
招募中
不适用
The GOAL27-6 StudyHead and Neck CancerNCT05859828East and North Hertfordshire NHS Trust60
Unknown
2 期
Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver GeneLung AdenocarcinomaNCT03905317Sun Yat-sen University66
